Novel mechanism of resistance to oxazolidinones, macrolides, and chloramphenicol in ribosomal protein L4 of the pneumococcus

Antimicrob Agents Chemother. 2005 Aug;49(8):3554-7. doi: 10.1128/AAC.49.8.3554-3557.2005.

Abstract

Two clinical Streptococcus pneumoniae isolates, identified as resistant to macrolides and chloramphenicol and nonsusceptible to linezolid, were found to contain 6-bp deletions in the gene encoding riboprotein L4. The gene transformed susceptible strain R6 so that it exhibited such resistance, with the transformants also showing a fitness cost. We demonstrate a novel bacterial mechanism of resistance to chloramphenicol and nonsusceptibility to linezolid.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Infective Agents / pharmacology*
  • Chloramphenicol / pharmacology
  • Drug Resistance, Multiple, Bacterial / genetics*
  • Humans
  • Macrolides / pharmacology
  • Microbial Sensitivity Tests
  • Mutation*
  • Oxazolidinones / pharmacology
  • Ribosomal Proteins / genetics*
  • Streptococcus pneumoniae / drug effects*
  • Streptococcus pneumoniae / genetics
  • Streptococcus pneumoniae / growth & development

Substances

  • Anti-Infective Agents
  • Macrolides
  • Oxazolidinones
  • Ribosomal Proteins
  • ribosomal protein L4
  • Chloramphenicol